From 2019 to 2022, the value of drug production in Russia varied across different categories, with annual values recorded in millions of rubles. Rows are categorized by medical purpose, including drugs for digestive tract diseases. This enables comparison of production volumes across different product groups and observation of overall market dynamics. The total row covers all medicinal products combined, with its value increasing from 404977 to 607549 million rubles
Drugs for treatment of the cardiovascular system: — million packages
Drugs for treatment of digestive tract and metabolic diseases: — million packages
Systemic antimicrobial drugs: — million vials
Systemic antimicrobial drugs: — million packages
Drugs for the treatment of musculoskeletal system — million packs
Drugs for treatment of skin diseases: — million vials
Drugs for treatment of digestive tract and metabolic diseases: — million ampoules
Drugs for treatment of skin diseases: — million packages
Drugs affecting haematopoiesis and blood: — million vials
Drugs for treatment of the cardiovascular system: — million ampoules
Rosstat data for 2019–2022. Rows: 38, periods: 4. Breakdown by items: Medicinal preparations1) – total, million roubles; Preparations for the treatment of diseases of the digestive system and…; Preparations for the treatment of diseases of the digestive system and…; Preparations for the treatment of diseases of the digestive system and…; Preparations affecting haematopoiesis and blood: — million packs and others
Medicinal preparations1) – total, million roubles: the indicator increased from 404 977 to 607 549 over 2019–2022 — by 50%. The highest value was 607 549 (2022), the lowest was 404 977 (2019). Of the 25 largest rows, 17 increased and 8 decreased
Row distinctions are based on the specialization of medicinal products, helping to assess the structure of pharmaceutical production. Total production value can be compared with indicators for specific therapeutic groups to identify more active development areas. Data is presented in millions of rubles and covers four years of annual monitoring. This approach allows for tracking changes in supply and demand across various medical segments
What is visible in these numbers
Top five values: Medicinal preparations1) – total, million roubles (607 549), Antineoplastic and immunomodulatory preparations (3 781), Preparations for the treatment of cardiovascular diseases (598), Preparations for the treatment of diseases of the digestive system (473), Antimicrobial preparations for systemic use (467). The gap between the highest and lowest is 132 076 times. The top five account for 99.7% of the total for all items — the distribution is heavily skewed toward the top
Annual observations, the dataset contains 4 observation periods. There are 100 values in the table out of 100 possible, that is 100%, meaning the table is almost completely filled
Statistics are updated annually and cover the period from 2019 to 2022. Information on production value is useful for pharmaceutical industry representatives, investors, and healthcare specialists. The data enables analysis of domestic medicinal product market volumes
How it is calculated
Source notes: In prices of the corresponding years
1) В ценах соответствующих лет.
Did you notice an error in this table? The parser is wrong, and most often one correction fixes many pages
Report an errorTypo is easier this way: highlight it and press
Ctrl + Enter